Hematologic Complications of Immune Checkpoint Inhibitors

por Davis, Elizabeth J., Salem, Joe‐Elie, Young, Arissa, Green, Jennifer R., Ferrell, P. Brent, Ancell, Kristin K., Lebrun‐Vignes, Benedicte, Moslehi, Javid J., Johnson, Douglas B.
Publicado 2019

Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma

por Tucker, Matthew D., Brown, Landon C., Chen, Yu-Wei, Kao, Chester, Hirshman, Nathan, Kinsey, Emily N., Ancell, Kristin K., Beckermann, Kathryn E., Davis, Nancy B., McAlister, Renee, Schaffer, Kerry, Armstrong, Andrew J., Harrison, Michael R., George, Daniel J., Rathmell, W. Kimryn, Rini, Brian I., Zhang, Tian
Publicado 2021

The Association between a Decrease in On-Treatment Neutrophil-to-Eosinophil Ratio (NER) at Week 6 after Ipilimumab Plus Nivolumab Initiation and Improved Clinical Outcomes in Metas...

por Chen, Yu-Wei, Tucker, Matthew D., Brown, Landon C., Yasin, Hesham A., Ancell, Kristin K., Armstrong, Andrew J., Beckermann, Kathryn E., Davis, Nancy B., Harrison, Michael R., Kaiser, Elizabeth G., McAlister, Renee K., Schaffer, Kerry R., Wallace, Deborah E., George, Daniel J., Rathmell, W. Kimryn, Rini, Brian I., Zhang, Tian
Publicado 2022